The Precision Peptide Company Inc. (CSE:BPC)

CSE:BPC Revenue

The Precision Peptide Company had revenue of 16.41K CAD in the quarter ending April 30, 2026. This brings the company's revenue in the last twelve months to 109.12K, up 10,003.80% year-over-year. In the fiscal year ending October 31, 2025, The Precision Peptide Company had annual revenue of 49.72K with 307.47% growth.

• Revenue (ttm): 109.12K
• Revenue Growth: +10,003.80%
• P/S Ratio: 199.10
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 21.73M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	49.72K	37.52K	307.47%
Oct 31, 2024	12.20K	-273.39K	-95.73%
Oct 31, 2023	285.59K	-295.40K	-50.84%
Oct 31, 2022	580.99K	463.57K	394.79%
Oct 31, 2021	117.42K	-	-

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error